A Covid-19 vaccine from China's Sinovac created antibodies among 97% of those who got the shot in a final stage trial in Indonesia but its efficacy has yet to be determined, says the company
Liveuamap is no longer providing historic data for previous years in free version
Buy one of our premium plans: Buy "PRO" from $7/month PRO account removes advertising, enables satellite maps, allowing to create own regions and opens additional features